Navigation Links
Humira in Medical News

Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease

Humira Will Retain its Status as Decision Resources' Clinical Gold Standard for Crohn's Disease Through 2017, According to a New Report from Decision Resources WALTHAM, Mass., Jan. 26, /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceuti...

Although Remicade and Humira Are Being Increasingly Prescribed for Crohn's Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies

Nearly One-Third of Surveyed Managed Care Organizations Levy Coinsurance Charges and Other Protocols on Remicade and Humira, According to a New Report from Decision Resources WALTHAM, Mass., March 4 /PRNewswire/ -- Decision Resources, one of the world's leading research ...

Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium

... tyrosine kinase (Syk) inhibitor fostamatinib disodium will likely precede TNF-alpha inhibitors such as Amgen/Wyeth/Takeda's Enbrel and Abbott/Eisai's humira in the treatment cascade for rheumatoid arthritis. Phase II data shows that fostamatinib disodium's efficacy is comparable to that of currently-availa...

U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic

...ary Advantages in Immune Biologics: Tightening Payer Control Offers Opportunities for Differentiation , Centocor Ortho Biotech's Remicade and Abbott's humira stand to most directly benefit from this strategy as these drugs are currently marketed and/or in development for multiple indications. Howeve...

Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA

...errupting a protein that causes inflammation and damage to bones, cartilage and other tissue. They include Remicade (infliximab), Enbrel (etanercept), humira (adalimumab), Cimzia (certolizumab pegol) and Simponi (golimumab). "FDA announced that it has completed its analysis of TNF blockers and has concl...

Brazil's Rheumatoid Arthritis Drug Market Will Grow $115 Million by 2013

...eaders were the tumor necrosis factor-alpha (TNF-alpha) inhibitors Abbott's humira and Schering-Plough's Remicade which recorded sales of $50 million and $43 ...in Rio de Janeiro, rheumatologists from Sao Paulo and Belo Horizonte prefer humira and Remicade, respectively. "Competition among TNF-alpha inhibito...

Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit

...trol Offers Opportunities for Differentiation , the majority of surveyed pharmacy directors say they currently cover Amgen/Wyeth's Enbrel and Abbott's humira solely as a pharmacy benefit, but cover other immune biologics as a medical benefit. The report finds that payers expect the shift of biolog...

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009

...orable 12.4 percent effect of exchange rates. U.S. humira sales were $635 million, up 20.9 percent. W...e Reported Pharmaceutical Products humira $635 20.9 $676 44.0 (2...ange Reported Pharmaceutical Products humira $1,311 32.8 (12....

Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts

...e world's largest drug market, the US, is due primarily to the inclusion of humira and Enbrel into Medicare Part D reimbursement in early 2006. New products t...ay treatment of autoimmune diseases include TNF inhibitors, such as Enbrel, humira and Remicade. New products in the market, such as Rituxan and Orencia made ...

Once Monthly Dosing: How Much of a Competitive Advantage is it? Rheumatologists Provide Insight in the Baseline Report of LaunchTrends(TM): SIMPONI(TM)

...he majority of RA patients likely to be placed on SIMPONI are expected to be switched from current biologic agents, primarily impacting use of Enbrel, humira and Remicade. The main advantages that clinicians perceive for SIMPONI compared to currently available agents are the monthly dosing regimen and self ...
Humira in Medical Technology

Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis

One Groundbreaking Study Showed 11 Percent Fewer RA Patients Reported Job Loss When Treated With HUMIRA Combination Therapy Compared to Methotrexate Alone BARCELONA, Spain, June 15, 2007 /PRNewswire-FirstCall/ -- Rheumatoid arthritis (RA) is one of the most common causes of disability in the Weste...

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

... Additional Analysis Shows humira Effectively Treats Adult Patients with Moderate t...ks, patients who had achieved adequate response to humira (as measured by PASI 75, or greater than 75 percen...ed into two groups. One group continued to receive humira and the other was given placebo. Beginning at week...

Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission

... Three of Four humira Patients from CHARM Study in Remission at One Year...study author. "In this study, many patients taking humira during a lengthened treatment period showed clinic...ongoing extension study focused on the efficacy of humira in maintaining remission and achieving response du...

Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis

... Fifth Disease Indication for humira Provides Patients with Visible Clearance of Infl...systemic therapies are medically less appropriate. humira should only be administered to patients who will b... or better at week 16 of treatment versus placebo. humira has 10 years of clinical trial experience beginnin...

Abbott's m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award

...he m2000 and HIV-1 viral load test, PathVysion and humira are just a few examples of the caliber of research...iated with congenital disorders and cancer. About humira In the United States, humira is approved by the Food and Drug Administration (F...

New Analysis of Data Shows Treatment With Abbott's Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease

... humira Data Showed 57 Percent Reduction in Risk of Hospit...ted to assess the effect of ongoing treatment with humira on the risk of hospitalization. At one year, this ...ent) were more than twice as likely as patients on humira (5.9 percent; p<0.01) to be hospitalized from Croh...

Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society

... - Co-Injection of rHuPH20 with humira Estimated to Increase the Maximal Steady State Sub...ging from 1,600 U to 12,800 U) and a fixed dose of humira (40 mg) injected every two weeks. Patients with rh...ctions were compared with regard to PK and safety. humira is a registered trademark of Abbott Laboratories. ...
Humira in Biological News

Researchers create mouse lacking key inflammation gene

...own and studied NF-kB transcriptional regulator. Drugs regulating TNF-alpha through the better-known NF-kB pathway such as Remicade, Embrel, and humira represent a multibillion market. The LITAF transcription factor offers a new approach to treating inflammatory disorders along with other immunologic...
Humira in Biological Technology

Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists

EXTON, Pa., May 28 /PRNewswire/ -- BioTrends Research Group today released its syndicated report TreatmentTrends (R) : Psoriasis , the fourth annual survey of U.S. Dermatologists (n=150). The report, based on results of an on-line survey fielded in April, highlights shifting trends in th...

Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline

...dministration (FDA) approval in the first quarter. Abbott also received approval from the Japanese Ministry of Health, Labour and Welfare for humira for the treatment of rheumatoid arthritis in patients with inadequate response to conventional therapy. -- SIMCOR(R), a fixed-dose combinatio...

Centocor/Janssen-Cilag's Ustekinumab Will Become the Gold Standard for Psoriasis By 2011

...b has advantages over sales-leading Enbrel on this attribute. "Clinical data and thought leader opinion indicate that ustekinumab and Abbott/Eisai's humira outperform Enbrel on efficacy and delivery measures," said Irene Koulinska, analyst at Decision Resources. "But the major improvement in efficacy offe...

Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis

...nd almost 20 percent achieving complete clearance, humira shows tremendous promise for physicians and people... decision granting the marketing authorization for humira as a treatment for psoriasis in the European Union...s indication. "The skin clearance we have seen in humira psoriasis clinical trials, combined with ten years...

First half of 2006 roundup: Big Pharma trumps biotech

...n to acquire new products that will generate in excess of $1 billion each. The case of Abbott Labs' stock price is a little strange as its new drug humira continues to grow beyond original expectations and has achieved additional FDA labeling approval. Furthermore, Abbott's move to aid Boston Scientific ...
Other Tags
(Date:12/17/2014)... TUESDAY, Dec. 16, 2014 (HealthDay News) -- Greater participation ... new study finds. Researchers followed kids in the ... to poor children in Los Angeles. Over two ... larger improvements in how the brain processes speech and ... Also, the benefits of active participation in music ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... work commitment is a big reason why, new research suggests. ... Mathias Basner, an assistant professor of sleep and chronobiology in ... A time-use survey of nearly 125,000 Americans, ages 15 ... exchanged for sleep. Short sleepers -- those who slept six ...
(Date:12/15/2014)... December 15, 2014 Veretekk.com, Inc. announced ... Ocean Avenue. JM Ocean Avenue has secured exclusive ... online automated marketing system. JM Ocean Avenue is ... merger of Ocean Avenue and JM International, with partial ... Billion per year company. , “After nearly 2 decades ...
(Date:12/15/2014)... SIMpalm, a leading mobile app development company , ... client, which allows users to keep track of wines ... the right wine. At the center of WineMatch ... and wine information. All this information is assembled to ... that are close counterparts to one another are called ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... study should reassure the millions of American women who have ... cancer. "There is no association between migraine and breast ... of medicine at Harvard Medical School. "There is no positive ... is no protective effect either." About 18 percent of ...
Breaking Medicine News(10 mins):Health News:Music Classes Boost Language Skills, Study Says 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ... 2015-2019"  report to their offering. ... advances in technology. With continuous advances in technology, ... the latest standard that meets the needs and ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
Other Contents